...
SYRAMICRO

Syra Health Corp. Class A Common Stock

HealthcareMedical - Care Facilities
$0.10
$0.00(+11.11%)
52W$0.03
$0.41
FinancialsValuationvs SOLV
Updated Mar 2, 12:00 AM
RSI51
RS Rating68/99
Beta0.78
Volatility239%
F-Score3/9
Mkt Cap$60000
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Syra Health Corp. Class A Common Stock is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 68), indicating performance broadly in line with the market. Earnings growth of 67% provides fundamental context to the price action. Investors should exercise caution due to high volatility (239% annualized), which requires wider risk management.

Relative Strength
68
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.78
vs S&P 500
DEFENSIVE
52W Position
18%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.09
50 SMA > 100 SMA$0.08
100 SMA > 150 SMA$0.08
150 SMA > 200 SMA$0.09

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.09+12.49%ABOVE
50 SMA$0.09+14.16%ABOVE
100 SMA$0.08+22.10%ABOVE
150 SMA$0.08+21.65%ABOVE
200 SMA$0.09+17.10%ABOVE

Price Performance

1D+11.1%
1W+11.1%
1M+23.5%
3M+33.3%
6M+37.0%
YTD+14.9%
1Y-75.3%
3Y-67.8%
52-Week Trading Range18% from low
$0.10
52W Low$0.03
52W High$0.41

Technical Indicators

RSI (14)NEUTRAL
51.5
305070
VCP ScoreCOOL
5/10
Base depth: 65.0%

Risk Profile

Beta
0.78
52W Vol
239%
ATR
$0.01
Max DD (1Y)
-87%

Volume Analysis

Today
—
50D Avg
12.0K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+54%
$-0.07
Q1'25+70%
$-0.07
Q2'25+95%
$-0.01
Q3'25+67%
$-0.02
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:—
3 Years:+78.22%
TTM:-3.14%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+74.38%

Stock Price CAGR

10 Years:-28.83%
5 Years:-49.35%
3 Years:-67.82%
1 Year:-75.31%

Return on Equity

10Y Avg:-278.7%
5Y Avg:-278.7%
3Y Avg:-278.7%
Last Year:-57.3%

Key Metrics

Market Cap$60000
Gross Margin20.7%
Net Margin-47.1%
Piotroski F-Score3/9

More SYRA Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

SYRA vs SOLVSOLVHCSGAMNCCRN

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 68 meansSYRA outperformed 68% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.78 means 22% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 3/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is SYRA in an uptrend right now?

SYRA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is SYRA overbought or oversold?

SYRA's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is SYRA outperforming the market?

SYRA has a Relative Strength (RS) Rating of 68 out of 99. SYRA is performing about average compared to the market.

Where is SYRA in its 52-week range?

SYRA is trading at $0.10, which is 24% of its 52-week high ($0.41) and 18% above its 52-week low ($0.03).

How volatile is SYRA?

SYRA has a Beta of 0.78 and 52-week volatility of 239%. It's less volatile than the S&P 500 - generally more stable.